These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Comparison of cyclosporine monitoring with trough levels to levels obtained 6 hours after the morning dose in heart transplant patients: a prospective randomized study. Cantarovich M; Latter D; Fitchett D Transplant Proc; 1997; 29(1-2):602-4. PubMed ID: 9123149 [No Abstract] [Full Text] [Related]
27. How many endomyocardial biopsies are necessary in the first year after heart transplantation? Sisson S; Jazzar A; Mischke L; Cooper DK; Zuhdi N Transpl Int; 1996; 9(3):243-7. PubMed ID: 8723194 [TBL] [Abstract][Full Text] [Related]
28. Long-term results and risk factors of quadruple immunosuppression in renal transplantation. Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496 [No Abstract] [Full Text] [Related]
29. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression. Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909 [No Abstract] [Full Text] [Related]
30. Increasing incidence of steroid resistant rejection in kidney transplantation. Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926 [No Abstract] [Full Text] [Related]
31. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation. Freise CE; Hebert M; Osorio RW; Nikolai B; Lake JR; Kauffman RS; Ascher NL; Roberts JP Transplant Proc; 1993 Apr; 25(2):1758-9. PubMed ID: 8470155 [No Abstract] [Full Text] [Related]
32. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation. Kitabayashi K; Munn SR; Sterioff S Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964 [No Abstract] [Full Text] [Related]
33. Relevance of positive lymphocytotoxic crossmatch and immunosuppressive regimens in the outcome of liver transplants. Charco R; Vargas V; Balsells J; Lázaro JL; Murio E; Jaurrieta E; Martorell J; Margarit C Transplant Proc; 1997; 29(1-2):461-2. PubMed ID: 9123082 [No Abstract] [Full Text] [Related]
34. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience. Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449 [No Abstract] [Full Text] [Related]